Patients with low AFR tended to have poorer liver function (high AST, GGT, and TBIL levels, high Child-Pugh scores, and low albumin levels), evaluated tumor marker levels (CEA, CA199, and CA125) and worse tumor conditions (larger tumor volume, poor tumor differentiation, and liver capsule invasion). This evidence concerns the gene CEACAM5 and neoplasm.